[e-med] L'Agence Européenne des médicaments lance EudraPharm

["ReMeD" <ReMeD@remed.org>]

L'Agence Européenne des médicaments lance EudraPharm

[L'EMEA a fait une base de données EudraPharm pour les médicaments enregistrés en Europe. Malheureusement, elle est limitée aux spécialités et aux produits enregistrés au niveau central. On ne peut pas faire de recherche à partir de la DCI. Les usagers des médicaments en Europe devront donc attendre... La base de données est accessible à cette adresse www.eudrapharm.eu
Ci-dessous le communiqué de presse qui aussi été diffusé par e-drug.CB]

*********************

London, 6 December 2006
Doc. Ref. EMEA/456119/2006  

PRESS RELEASE

European Medicines Agency launches EudraPharm - the European medicines
database

The European Medicines Agency has launched a new public database designed to
facilitate access to information about medicines available in the European
Union.

The database, called EudraPharm, is a long-term project to give on-line
access to information about all medicines, both human and veterinary,
available to EU citizens. The database can be accessed at: www.eudrapharm.eu

In the first phase the database gives access to information about medicines
that have been authorised by the European Commission following assessment by
the European Medicines Agency. These are mainly innovative new medicines,
intended for treatment of diseases such as different types of cancer,
AIDS/HIV, diabetes, neurodegenerative disorders and rare conditions ('orphan
drugs'). All of these so-called 'centrally authorised medicines' are
approved for use in each of the 25 EU Member States and also in Iceland,
Liechtenstein and Norway.

European Commission Vice-President Günter Verheugen, responsible for
Enterprise and Industry, welcomed EudraPharm as a "great initiative to
provide consumers with more information about their medicines. This database
gives people the opportunity to check if they are in doubt, which creates a
safer environment for users of medicines."

EMEA Executive Director Thomas Lönngren said: "Once fully developed, this
database will be the reference point for independent information about all
medicines available to Europeans, no matter whether these medicines have
been authorised at EU or national level."

The database includes the summary of product characteristics, package
leaflets and the labelling of medicinal products. It currently gives access
to information only in English, but information in the other official EU
languages will be available at a later phase, together with improved search
functions. The Agency is working with medicines agencies in each Member
State and the European Commission on the long-term objective of including
information on all medicines approved through national procedures.
--ENDS--

NOTES:

1. All information in EudraPharm is updated weekly to ensure that the
latest information is always available.
2. EudraPharm was created in accordance with Article 57, 1(l) of
Regulation (EC) No 726/2004.
3. More information on the work of the European Commission's
pharmaceutical unit can be found here.
4. This press release, together with other information about the work
of the European Medicines Agency, can be found on the EMEA website:
www.emea.europa.eu.

Media enquiries only to 
Ton van Lierop (for the European Commission)
Tel. (32-2) 296 65 65, Fax (32-2) 296 30 38, E-mail:
ton.van-lierop@ec.europa.eu 
Martin Harvey Allchurch (for the European Medicines Agency)
Tel. (44-20) 74 18 84 27, Fax (44-20) 74 18 84 09, E-mail:
press@emea.europa.eu